Case Presentation 2: Transplant-Ineligible NDMM and Treatment With the DRd Regimen
May 24th 2022Experts review a second patient case wherein transplant-ineligible newly diagnosed multiple myeloma was treated with the daratumumab, lenalidomide and dexamethasone regimen and how updated data from the MAIA trial can be incorporated into clinical practice.
Shining a Warm Light on Cryoglobulinemia
November 15th 2013We recommend screening for cryoglobulinemia in all patients with HCV infection, livedo reticularis, vasculitic cutaneous ulcers, positive rheumatoid factor or rheumatoid vasculitis, membranoproliferative glomerulonephritis, or atypical Waldenström macroglobulinemia.
Treatment of Immunoglobulin Light Chain (Primary or AL) Amyloidosis
June 15th 2011This review of the various available options for the treatment of systemic amyloidosis is designed to help the clinician determine which patients are candidates for stem cell transplantation and which should be treated with conventional chemotherapy.